JB Chem & Pharma

₹1772.5 8.4 | 0.5%

WEBSITE BSE:506943 NSE : J.B.CHEMICAL 09 Dec, 11:41

Market Cap ₹27546 Cr.

Stock P/E 49.8

P/B 8.6

Current Price ₹1772.5

Book Value ₹ 206.7

Face Value 1

52W High ₹2029

Dividend Yield 0.69%

52W Low ₹ 1400

Edit Ratio

JB Chem & Pharma Research see more...

JB Chemicals: Business Analysis

Overview Inc. Year: 1976Industry: Pharmaceuticals & Drugs

J. B. Chemicals & Pharmaceuticals Ltd is an pharmaceutical company. It is an incorporated, research-orientated organization, which is focused on imparting products both in India and International markets. The Company manufactures and markets a range of herbal remedies, pharmaceutical formulations, active pharmaceutical ingredient (APIs). The Company is engaged in manufacturing distinctiveness merchandise that comprises various pharmaceutical dosage forms like drugs, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, liquids and pills. The Company's brands include Rantac (anti-peptic ulcerant), Cilacar (calcium channel blocker), Nicardia (calcium channel blocker) and Metrogyl (amoebicides).

JB Chem & Pharma Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

JB Chem & Pharma Quarterly Results

#(Fig in Cr.)	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Net Sales	785	809	793	762	896	882	845	862	1004	1001
Other Income	1	1	3	5	6	8	7	17	6	10
Total Income	786	811	796	767	902	889	852	878	1010	1011
Total Expenditure	612	625	618	599	664	638	621	664	724	730
Operating Profit	174	186	178	168	238	251	230	215	286	280
Interest	6	8	8	14	12	10	12	9	6	2
Depreciation	26	28	28	32	31	32	34	41	41	42
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	142	150	141	122	194	209	184	165	240	237
Provision for Tax	37	39	35	35	52	58	50	38	63	62
Profit After Tax	105	111	106	88	142	151	134	126	177	175
Adjustments	-0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	105	111	106	88	142	151	134	126	177	175
Adjusted Earnings Per Share	6.8	7.2	6.9	5.7	9.2	9.7	8.6	8.1	11.4	11.2

JB Chem & Pharma Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	1022	1144	1232	1368	1414	1643	1775	2043	2424	3149	3484	3712
Other Income	38	11	57	54	55	41	51	117	40	10	42	40
Total Income	1060	1155	1288	1422	1469	1685	1826	2159	2464	3159	3526	3751
Total Expenditure	874	964	1026	1140	1215	1337	1397	1486	1882	2454	2592	2739
Operating Profit	186	191	263	283	254	347	428	673	583	706	934	1011
Interest	6	7	11	5	3	5	3	7	5	36	44	29
Depreciation	28	39	41	47	57	56	66	69	73	114	138	158
Exceptional Income / Expenses	-65	0	0	0	0	0	-10	0	0	0	0	0
Profit Before Tax	87	146	212	230	194	287	349	597	505	555	752	826
Provision for Tax	26	45	50	46	55	93	77	148	119	145	199	213
Profit After Tax	61	100	163	184	139	194	272	449	386	410	553	612
Adjustments	0	0	-0	-0	-0	-1	-0	-1	-1	-0	0	0
Profit After Adjustments	61	100	163	184	138	193	272	448	385	410	553	612
Adjusted Earnings Per Share	3.6	5.9	9.6	10.9	8.3	12.1	17.6	29	24.9	26.5	35.6	39.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	11%	19%	16%	13%
Operating Profit CAGR	32%	12%	22%	18%
PAT CAGR	35%	7%	23%	25%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	21%	30%	55%	32%
ROE Average	21%	20%	21%	16%
ROCE Average	25%	25%	27%	20%

JB Chem & Pharma Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	1043	995	1184	1364	1442	1480	1435	1810	2134	2480	2923
Minority's Interest	0	0	2	2	3	3	3	4	4	0	0
Borrowings	0	0	0	0	0	0	0	0	0	383	24
Other Non-Current Liabilities	31	32	31	27	46	65	63	72	475	609	442
Total Current Liabilities	276	460	797	693	736	782	516	687	455	626	1288
Total Liabilities	1351	1487	2014	2086	2226	2329	2017	2572	3069	4098	4677
Fixed Assets	311	329	440	679	640	621	651	634	1277	1901	2004
Other Non-Current Assets	60	258	391	200	78	120	90	45	468	598	400
Total Current Assets	981	901	1182	1207	1509	1589	1276	1894	1325	1599	2273
Total Assets	1351	1487	2014	2086	2226	2329	2017	2572	3069	4098	4677

JB Chem & Pharma Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	156	12	-5	7	-21	21	32	26	22	57	77
Cash Flow from Operating Activities	-14	127	140	201	123	194	276	315	170	626	801
Cash Flow from Investing Activities	-142	-112	-28	-45	-21	-28	24	-231	2	-962	-404
Cash Flow from Financing Activities	12	-1	-100	-184	-60	-156	-306	-87	-138	357	-385
Net Cash Inflow / Outflow	-144	13	13	-28	43	11	-6	-3	34	20	11
Closing Cash & Cash Equivalent	12	25	9	-21	21	32	26	22	57	77	88

JB Chem & Pharma Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	3.63	5.92	9.58	10.85	8.28	12.06	17.6	28.98	24.93	26.48	35.61
CEPS(Rs)	5.28	8.2	12.02	13.65	11.71	15.55	21.91	33.46	29.68	33.89	44.52
DPS(Rs)	1.5	7	2.5	0.5	1	2.5	5.5	8.25	8.25	8.88	12.25
Book NAV/Share(Rs)	61.53	58.65	69.79	80.39	86.25	92.24	92.87	117.09	134.02	152.42	179.35
Core EBITDA Margin(%)	14.33	15.54	16.73	16.72	14.09	18.61	21.28	27.23	21.81	21.28	24.76
EBIT Margin(%)	9.03	13.15	18.1	17.2	13.97	17.75	19.84	29.58	20.5	18.09	22.08
Pre Tax Margin(%)	8.45	12.56	17.23	16.8	13.72	17.47	19.66	29.22	20.29	16.98	20.85
PAT Margin (%)	5.95	8.66	13.21	13.48	9.81	11.8	15.35	21.96	15.51	12.54	15.33
Cash Profit Margin (%)	8.65	12	16.55	16.93	13.84	15.19	19.09	25.32	18.44	16.04	19.17
ROA(%)	4.64	7.08	9.29	8.99	6.43	8.52	12.53	19.55	13.69	11.44	12.6
ROE(%)	5.99	9.86	14.93	14.48	9.89	13.28	18.69	27.64	19.89	18.51	21.49
ROCE(%)	8.5	13.49	17.83	16.87	13.7	19.59	23.71	36.53	25.48	22.79	25.23
Receivable days	75.3	78.41	79.28	71.84	73.15	67.63	67.22	65.62	69.29	63.16	63.93
Inventory Days	42.16	44.83	50.12	51.77	53.43	50.81	53.31	55.59	55.55	46.91	47.24
Payable days	70.5	73.91	62.53	62.76	70.44	69.69	82.55	92.33	89.07	72.35	91.86
PER(x)	17.68	16.9	13.01	15.99	18.68	14.91	14.44	21.63	31.59	37.21	46.32
Price/Book(x)	1.04	1.71	1.79	2.16	1.79	1.95	2.74	5.35	5.88	6.47	9.2
Dividend Yield(%)	2.34	7	2	0.29	0.65	1.39	2.16	1.32	1.05	0.9	0.74
EV/Net Sales(x)	1.14	1.57	1.86	2.18	1.83	1.75	2.21	4.74	5.01	4.99	7.42
EV/Core EBITDA(x)	6.29	9.42	8.74	10.54	10.15	8.28	9.17	14.4	20.84	22.28	27.68
Net Sales Growth(%)	17.98	11.97	7.64	11.1	3.32	16.23	8	15.09	18.69	29.91	10.63
EBIT Growth(%)	-14.22	63.18	46.27	5.58	-16.09	47.71	20.75	71.55	-15.58	15.93	34.59
PAT Growth(%)	-22.59	63.27	61.99	13.37	-24.77	39.83	40.43	64.66	-13.93	6.21	34.79
EPS Growth(%)	-22.61	63.12	61.87	13.24	-23.72	45.66	45.99	64.66	-13.98	6.22	34.46
Debt/Equity(x)	0.09	0.13	0.16	0.04	0.02	0.02	0.02	0.02	0.01	0.23	0.13
Current Ratio(x)	3.55	1.96	1.48	1.74	2.05	2.03	2.47	2.76	2.91	2.56	1.77
Quick Ratio(x)	3.06	1.63	1.25	1.45	1.76	1.72	1.94	2.25	2.01	1.87	1.37
Interest Cover(x)	15.74	22.33	20.94	43.81	56.54	62.74	108.09	83.43	99.6	16.4	17.95
Total Debt/Mcap(x)	0.09	0.08	0.09	0.02	0.01	0.01	0.01	0	0	0.04	0.01

JB Chem & Pharma Shareholding Pattern

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	54	53.96	53.95	53.93	53.91	53.86	53.83	53.78	53.77	53.74
FII	8.85	8.66	8.8	8.63	9.54	10.05	10.35	11.05	12.17	13.61
DII	17.8	18.48	18.54	19.08	18.65	18.58	18.54	18.39	17.62	16.83
Public	19.35	18.91	18.71	18.36	17.91	17.51	17.28	16.78	16.43	15.82
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	4.17	4.17	4.17	4.17	4.17	8.35	8.35	8.35	8.35	8.35
FII	0.68	0.67	0.68	0.67	0.74	1.56	1.6	1.72	1.89	2.11
DII	1.38	1.43	1.43	1.48	1.44	2.88	2.87	2.85	2.74	2.61
Public	1.5	1.46	1.45	1.42	1.39	2.71	2.68	2.6	2.55	2.46
Others	0	0	0	0	0	0	0	0	0	0
Total	7.73	7.73	7.74	7.74	7.74	15.5	15.5	15.52	15.52	15.53

Pros

Company has delivered good profit growth of 23% CAGR over last 5 years
Company has reduced debt.
Company is almost debt free.

Cons

Debtor days have increased from 72.35 to 91.86days.
Stock is trading at 8.6 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

JB Chem & Pharma News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

JB Chem & Pharma

Add Watchlist

JB Chem & Pharma Research see more...

Overview Inc. Year: 1976Industry: Pharmaceuticals & Drugs

JB Chem & Pharma Share Price

Alert Data

Quarterly Price

Peer Comparison

JB Chem & Pharma Quarterly Results

JB Chem & Pharma Profit & Loss

Growth Rates

JB Chem & Pharma Balance Sheet

JB Chem & Pharma Cash Flow

JB Chem & Pharma Ratios

JB Chem & Pharma Shareholding Pattern

JB Chem & Pharma News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!